Dissemination of IMP-1 and OXA Type β-Lactamase in Carbapenem-resistant Acinetobacter baumannii

Korean Journal of Laboratory Medicine

Volumn 28, Issue 1, 2008, Pages 16-23

  Sung, Ji Youn ^a   Kwon, Kye Chul ^a   Park, Jong Woo ^a   Kim, Yeon Suk ^a   Kim, Ji Myung ^b   Shin, Kyeong Seob ^c   Kim, Jong Wan ^d   Ko, Chi Seon ^a   Shin, So Youn ^a   Song, Jeong Hoon ^a   Koo, Sun Hoe ^a  

^a Chungnam National University College of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Dankook University College of Medicine   (South Korea)

Author keywords

A. baumannii; Mbl; Oxa 2

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE IMP 1; BETA LACTAMASE OXA 2; BETA-LACTAMASE IMP-1; BETA-LACTAMASE OXA-2; CARBAPENEM DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BIOSYNTHESIS; DISK DIFFUSION; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; POLYMERASE CHAIN REACTION;

EID: 58149112554     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.1.16     Document Type: Article

References (33)

1. Bergogne-berezin E and Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-65. (Pubitemid 26123943)
2. Poirel L and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006;12:826-36. (Pubitemid 44151282)
3. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 2003;51:565-74. (Pubitemid 36336148)
4. Clark RB. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein. J Antimicrob Chemother 1996;38:245-51. (Pubitemid 26302585)
5. Afzal-shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001;45:583-8. (Pubitemid 32105297)
6. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 2005;43:4826-9. (Pubitemid 41298286)
7. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999;43: 1584-90. (Pubitemid 29331232)
8. Lee K, Ha GY, Shin BM, Kim JJ, Kang JO, Jang SJ, et al. Metallo-betalactamase- producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp. Diagn Microbiol Infect Dis. 2004;50:51-8. (Pubitemid 39360262)
9. Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, et al. Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol 2004;42:5256-63. (Pubitemid 39506238)
10. Wachino J, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, et al. Molecular characterization of a cephamycin-hydrolyzing and inhibitor- resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop. Antimicrob Agents Chemother 2004;48:2905-10. (Pubitemid 38989154)
11. Aubert D, Poirel L, Chevalier J, Leotard S, Pages JM, Nordmann P. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001;45:1615-20. (Pubitemid 32466325)
12. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006; 50:2941-5. (Pubitemid 44396395)
13. Scaife W, Young HK, Paton RH, Amyes SG. Transferable imipenemresistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 1995;36:585-6.
14. Girlich D, Naas T, Leelaporn A, Poirel L, Fennewald M, Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis 2002;34:603-11. (Pubitemid 34165322)
15. Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 2001;45:2598-603. (Pubitemid 32801916)
16. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991;19:6823-31. (Pubitemid 21913121)
17. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:147-51.
18. Schreckenberger PC and Graevenitz A. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods. In Murray PR, Baron EJ, et al. eds. Manual of clinical microbiology. 7th ed. Washington D.C.: ASM Press, 1999; 539-60.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement, M100-S15. Wayne, PA: CLSI, 2005.
20. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol 2005;43:2241-5. (Pubitemid 40656234)
21. Oh EJ, Lee S, Park YJ, Park JJ, Park K, Kim SI, et al. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamse. J Microbiol Methods 2003;54:411-8. (Pubitemid 36773983)
22. De Champs C, Poirel L, Bonnet R, Sirot D, Chanal C, Sirot J, et al. Prospective survey of beta-lactamases produced by ceftazidimeresistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 2002;46:3031-4.
23. Heritier C, Dubouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem- hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 2005;55:115-8. (Pubitemid 40192624)
24. Kang JH, Bae IK, Kwon SB, Jeong SH, Lee JW, Lee WG, et al. Prevalence of Ambler class A extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J Clin Microbio 2005;8:17-25.
25. Naas T, Benaoudia F, Massuard S, Nordmann P. Integron-located VEB-1 extended-spectrum beta-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J Antimicrob Chemother 2000;46:703-11.
26. Park JH, Lee SH, Jeong SH, Kim BN, Kim KB, Yoon JD, et al. Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extended spectrum β-lactamase from Korean hospitals. Korean J Lab Med 2003;23:18-24.
27. Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol 2006;44:423-31.
28. Nordmann P and Guibert M. Extended-spectrum -lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998;42:128-31.
29. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 2005;56: 122-7. (Pubitemid 41418345)
30. Tognim MC, Gales AC, Penteado AP, Silbert S, Sader HS. Dissemination of IMP-1 metallo-beta-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol 2006;27:742-7. (Pubitemid 44271957)
31. Dalla-Costa LM, Coelho JM, Souza HA, Castro ME, Stier CJ, Bragagnolo KL, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003;41:3403-6. (Pubitemid 36842361)
32. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007;65:204-11.
33. Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii- calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006;27:654-8. (Pubitemid 44271943)